<code id='3003690433'></code><style id='3003690433'></style>
    • <acronym id='3003690433'></acronym>
      <center id='3003690433'><center id='3003690433'><tfoot id='3003690433'></tfoot></center><abbr id='3003690433'><dir id='3003690433'><tfoot id='3003690433'></tfoot><noframes id='3003690433'>

    • <optgroup id='3003690433'><strike id='3003690433'><sup id='3003690433'></sup></strike><code id='3003690433'></code></optgroup>
        1. <b id='3003690433'><label id='3003690433'><select id='3003690433'><dt id='3003690433'><span id='3003690433'></span></dt></select></label></b><u id='3003690433'></u>
          <i id='3003690433'><strike id='3003690433'><tt id='3003690433'><pre id='3003690433'></pre></tt></strike></i>

          fashion

          fashion

          author:hotspot    Page View:9181
          Tome cofounders Jonathan Gootenberg, left, and Omar Abudayyeh, a scientific team that's trying to reinvent gene editing for a new era of biotech innovation.
          Suzanne Kreiter/Globe staff

          WATERTOWN — Their brainstorming began in an MIT class in 2010 when the eager undergrads shot each other emails about how to solve a bioengineering equation. It has continued for 14 years over sushi dinners, between Marvel movies, and during rowing-machine workouts.

          Together, Omar Abudayyeh, 33, and Jonathan Gootenberg, 32, have probed the mysteries of genomic editing and COVID detection. They co-published 10 scientific papers, helped launch two medical-diagnostic companies, and cofounded a Watertown startup, Tome Biosciences, that reengineers genes and cells to cure diseases. They also run the Abudayyeh-Gootenberg Lab at Harvard.

          advertisement

          Gootenberg and Abudayyeh are an unusual pair, two scientists — a Jewish American and a Palestinian American — who prefer working together in a field that often draws solitary researchers and rewards individual achievement.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          At least 13 dead in Texas as scorching temps continue
          At least 13 dead in Texas as scorching temps continue

          1:17FirefighterEMTWilliamDorseyandfirefighterEMTRodrigoPinedatreatamigrantwomansufferingfromheatexha

          read more
          Study says nonprofit hospitals fall short in charity care spending
          Study says nonprofit hospitals fall short in charity care spending

          AdobeAnewstudyofhospitals’charitycarespendingsuggestsnonprofithospitalsreallyaren’tthatdifferentfrom

          read more
          Hepatitis C has a cure — but many Americans still lack access to it
          Hepatitis C has a cure — but many Americans still lack access to it

          AdobeIn2005,NickVoyleswasdiagnosedwithhepatitisCafterbeingreleasedfromfiveyearsofincarceration.Anurs

          read more

          Readout Newsletter: Merck, Vertex, and Viking updates

          MelEvans/APNewbiotechnewsletterlaunchingthisThursday. Don’tmissout.Hello,everyone.Damianherewithaloo